Drawing for LIQITOMIC

USPTO serial 79455715

LIQITOMIC

Reviewed by CopyMark Law Group

Status 641Office Action
Filing date
Status date
Registration date
—
Examiner
CLARK, MICHAEL J.
Law office
TMO LAW OFFICE 121

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 641: Status 641 means the USPTO mailed a non-final Office Action identifying issues with your application. You typically have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

Need help with LIQITOMIC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Waste treatment chemicals; chemicals for the treatment of clinical, medical, biomedical and biohazardous waste; chemicals for treating hazardous waste; waste digestant for use in clinical waste treatment systems; sodium hydroxide; caustic alkaline hydroxides; caustic potassium hydroxide; caustic sodium hydroxideACTIVE—
005Disinfectants; disinfectants for hygiene purposes; disinfectants for sanitary purposes; sterilizing preparationsACTIVE—
007Waste treatment units; continuous waste treatment units; waste disposal units; continuous waste disposal units; waste processing units; continuous waste processing units; industrial chemical reactors; parts and fittings for all the aforesaid goodsACTIVE—
011Reactor systems being industrial chemical treatment installations; reactors being waste treatment systems; reactors being continuous waste treatment systems; waste and continuous waste processing machines using heat and chemical breakdown processes; waste and continuous waste processing machines using hydrolysis; bioreactors for use in the treatment of waste; heating apparatus for use in the treatment of waste material; reactor systems being waste processing machines used in the biotechnology, pharmaceutical, medical and biopharmaceutical industries; reactor systems being continuous waste processing machines used in the biotechnology, pharmaceutical, medical and biopharmaceutical industries; sterilizing installations and apparatus; sterilizers and sterilization units for medical purposes; disinfectant apparatus; disinfectant apparatus for medical purposes; waste disposal incinerators; parts and fittings for all the aforesaid goodsACTIVE—
037Medical waste disposal; hazardous waste disposal services; medical waste, blood and bodily fluid cleaning and disposal services; medical waste, blood and bodily fluid disinfection services; waste disposal for others, namely a cleaning service; disinfecting; consultancy, information and advisory services relating to all the aforesaid servicesACTIVE—
040Waste treatment services; continuous waste treatment services; medical and clinical waste treatment services; biomedical and biohazardous waste treatment services; biomedical and biohazardous continuous waste treatment services; waste treatment services by hydrolysis; continuous waste treatment services by hydrolysis; waste processing and continuous waste processing; waste treatment and processing services in the biotechnology, pharmaceutical, medical, clinical and biopharmaceutical industries; continuous waste treatment and processing services in the biotechnology, pharmaceutical, medical, clinical and biopharmaceutical industries; chemical treatment of waste products; medical waste, blood and bodily fluid decontamination services; recycling of waste; recycling of medical waste; decontamination of hazardous materials and hazardous waste treatment services; waste incineration; decontamination of waste; providing technical information in the field of waste management and continuous waste management; technical consulting in the field of biotechnology, pharmaceutical, medical, clinical and biopharmaceutical waste management; consultancy, information and advisory services relating to all the aforesaid servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 12, 2026RFNTREFUSAL PROCESSED BY IB—
Oct 27, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 20, 2026RFRRREFUSAL PROCESSED BY MPU—
Aug 12, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 11, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 11, 2026DOCKASSIGNED TO EXAMINER—
Aug 10, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 10, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 6, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance